Larimar Therapeutics, Inc. (LRMR)
NASDAQ: LRMR · Real-Time Price · USD
3.170
-0.120 (-3.65%)
At close: Jun 5, 2026, 4:00 PM EDT
3.190
+0.020 (0.63%)
After-hours: Jun 5, 2026, 7:57 PM EDT
Larimar Therapeutics Market Cap
Larimar Therapeutics has a market cap or net worth of $330.89 million as of June 5, 2026. Its market cap has increased by 167.77% in one year.
Market Cap
330.89M
Enterprise Value
134.29M
1-Year Change
167.77%
Ranking
Category
Stock Price
$3.17
Market Cap Chart
Since May 29, 2020, Larimar Therapeutics's market cap has increased from $113.38M to $330.89M, an increase of 191.84%. That is a compound annual growth rate of 19.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 330.89M | 1.47% |
| Dec 31, 2025 | 326.10M | 32.06% |
| Dec 31, 2024 | 246.93M | 23.61% |
| Dec 29, 2023 | 199.77M | 11.79% |
| Dec 30, 2022 | 178.70M | -6.49% |
| Dec 31, 2021 | 191.10M | -41.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| May 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Puma Biotechnology | 357.82M |
| Shattuck Labs | 351.20M |
| Lexeo Therapeutics | 343.14M |
| Atea Pharmaceuticals | 340.12M |
| Artiva Biotherapeutics | 332.83M |
| Enanta Pharmaceuticals | 328.00M |
| Greenwich LifeSciences | 326.59M |
| Verastem | 326.01M |